UY35909A - Síntesis de ent-progesterona y sus productos intermedios - Google Patents

Síntesis de ent-progesterona y sus productos intermedios

Info

Publication number
UY35909A
UY35909A UY0001035909A UY35909A UY35909A UY 35909 A UY35909 A UY 35909A UY 0001035909 A UY0001035909 A UY 0001035909A UY 35909 A UY35909 A UY 35909A UY 35909 A UY35909 A UY 35909A
Authority
UY
Uruguay
Prior art keywords
ent
synthesis
progesterona
intermediate products
products
Prior art date
Application number
UY0001035909A
Other languages
English (en)
Inventor
Daniel Emil Levy
Zhang Faliang
Zhan Xinxi
Original Assignee
Prevacus Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prevacus Inc filed Critical Prevacus Inc
Publication of UY35909A publication Critical patent/UY35909A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/26—Radicals substituted by doubly bound oxygen or sulfur atoms or by two such atoms singly bound to the same carbon atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/72—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J15/00—Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers
    • C07J15/005—Retrosteroids (9 beta 10 alfa)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/006—Ketals at position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general
    • C07J75/005—Preparation of steroids by cyclization of non-steroid compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)

Abstract

La presente invención se refiere a la síntesis de ent-progesterona y sus compuestos intermedios.
UY0001035909A 2013-12-20 2014-12-19 Síntesis de ent-progesterona y sus productos intermedios UY35909A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361919420P 2013-12-20 2013-12-20

Publications (1)

Publication Number Publication Date
UY35909A true UY35909A (es) 2015-07-31

Family

ID=53399300

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001035909A UY35909A (es) 2013-12-20 2014-12-19 Síntesis de ent-progesterona y sus productos intermedios

Country Status (18)

Country Link
US (1) US20150175650A1 (es)
EP (1) EP3083656A1 (es)
JP (1) JP2017502031A (es)
CN (1) CN105980396B (es)
AR (1) AR098879A1 (es)
AU (1) AU2014364850A1 (es)
BR (1) BR112016014000A2 (es)
CA (1) CA2934466A1 (es)
EA (1) EA201691074A1 (es)
IL (1) IL246258A0 (es)
MA (1) MA39126B1 (es)
MX (1) MX2016008167A (es)
PH (1) PH12016501201A1 (es)
SG (1) SG11201604982XA (es)
TN (1) TN2016000252A1 (es)
TW (1) TW201538519A (es)
UY (1) UY35909A (es)
WO (1) WO2015095339A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017100988A (ja) * 2015-12-01 2017-06-08 アサヒグループホールディングス株式会社 光学活性なヒドロキシ脂肪酸の製造方法
IT201700004904A1 (it) * 2017-01-18 2018-07-18 Ind Chimica Srl PROCESSO PER LA PREPARAZIONE DI 9β,10α-PROGESTERONE (RETROPROGESTERONE)
EP4007765A4 (en) * 2019-08-02 2023-08-23 Enterin, Inc. HUMAN SQUALAMIN DERIVATIVES, COMPOSITIONS CONTAINING THEM, AND METHODS OF USE THEREOF
JP2022543242A (ja) * 2019-08-02 2022-10-11 エンターイン、 インコーポレイテッド ヒトアミノステロールｅｎｔ－０３化合物、それを含む関連組成物、およびそれを使用する方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2955684A1 (en) * 2008-02-26 2009-09-03 Emory University Steroid analogues for neuroprotection
WO2010088409A2 (en) * 2009-01-30 2010-08-05 Emory University Methods of neuroprotection using neuroprotective steroids and a vitamin d
EP2763679A4 (en) * 2011-10-07 2016-06-01 Univ Florida State Res Found PROPHYLACTIC AND POSTACLE USE OF PROGESTERONE FOR BETTER TREATMENT RESULTS IN BRAIN DISORDER

Also Published As

Publication number Publication date
JP2017502031A (ja) 2017-01-19
AU2014364850A1 (en) 2016-07-07
SG11201604982XA (en) 2016-07-28
MA39126A3 (fr) 2019-04-30
MA39126A2 (fr) 2018-08-31
CN105980396B (zh) 2019-03-22
CN105980396A (zh) 2016-09-28
EP3083656A1 (en) 2016-10-26
WO2015095339A1 (en) 2015-06-25
BR112016014000A2 (pt) 2017-08-08
PH12016501201A1 (en) 2016-08-15
CA2934466A1 (en) 2015-06-25
EA201691074A1 (ru) 2017-02-28
MA39126B1 (fr) 2020-03-31
MX2016008167A (es) 2017-04-27
IL246258A0 (en) 2016-08-02
US20150175650A1 (en) 2015-06-25
AR098879A1 (es) 2016-06-22
TW201538519A (zh) 2015-10-16
TN2016000252A1 (en) 2017-10-06

Similar Documents

Publication Publication Date Title
ECSP17029371A (es) Dihidropirrolopiridinas inhibidoras de ror-gamma
BR112015029933A2 (pt) método de produção de tagatose
CR20140510A (es) Nucleósidos de espirooxetano de uracilo
BR112016000903A2 (pt) anticorpos
GB201421334D0 (en) Synthesis of aeizeolite
TR201906366T4 (tr) Polisiklik-karbamoilpiridon bileşiklerinin sentezi.
CR20160184A (es) Piperidil-etil-pirimidina sustituido como inhibidor de ghrelin o-acil transferasa
BR112014001219A2 (pt) perfume
UY34644A (es) Polipéptidos de unión a cx3cr1
TR201904601T4 (tr) Hidrolize edilmiş keratinöz materyal üretmek için yöntem.
CR20150084A (es) 2-oxo-2,3-dihidro-indoles
BR112016003736A2 (pt) síntese de bifenilalaninol via novos intermed!ários
TWD177145S (zh) 自行車用速度計
UY35909A (es) Síntesis de ent-progesterona y sus productos intermedios
CO7111295A2 (es) Anticuerpo anti-rob04
CR20150087A (es) Derivados de pirazol-carboxamida
CL2017000645A1 (es) Síntesis de ent-progesterona e intermediarios de la misma
HK1211294A1 (en) Asymmetric synthesis of a substituted pyrrolidine-2-carboxamide -2-
MX2016007186A (es) Nuevo procedimiento de sintesis de la agomelatina.
CR20150028A (es) Derivados de ariletinilo
CR20140531A (es) Derivados de ariletinilo
MX2015012902A (es) Sintesis de ent-progesterona e intermediarios de la misma.
FI20155596A (fi) Tuotevaihteluiden vähentäminen varianssinositusanalyysin avulla
BR112017020037A2 (pt) pastas minerais
CR20150484A (es) Método de producción de compuestos de piridazinona

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20211230